Implantable cardiac devices are a vital treatment option in the management of
tachy/brady-arrhythmias and heart failure with conduction disease. In the recent
years, these devices have become increasingly sophisticated, with high
implantation success rates and longevity. However, these devices are not without
risks and complications, which need to be carefully considered before
implantation. In an era of rapidly evolving cardiac device therapies, this review
article will provide an update on the literature and outline some of the emerging
technologies that aim to maximise the efficiency of implantable devices and
reduce complications. We discuss novel pacing techniques, including alternative
pacing sites in anti-bradycardia and biventricular pacing, as well as the latest
evidence surrounding leadless device technologies and patient selection for
implantable device therapies.